Stem Cell Treatment for Dry AMD Moves Closer to Human Trials

Some 80% of age-related macular degeneration (AMD) in seniors is of the dry type, for which there is no treatment available. However, it is encouraging to note that recent animal studies have demonstrated success in using plurpotent stem cells to create cells in the retina to replace some of those lost in the AMD disease process. Hopefully similar trials will be approved to begin in humans in the very near future and will show promising results.

Read the Full Article

Request Eye Exam